Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapy

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 4023-4031

  Krieter, Detlef H ^a   Fischer, Regina ^a   Merget, Karin ^b   Lemke, Horst Dieter ^b,c   Morgenroth, Andreas ^d   Canaud, Bernard ^e   Wanner, Christoph ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b eXcorLab GmbH   (Germany)

^c Membrana GmbH   (Germany)

^d Dialysis Center   (Germany)

^e UNIV MONTPELLIER   (France)

Author keywords

atherosclerosis; end stage renal disease; endothelial progenitor cells; haemodialysis; uraemic toxins

Indexed keywords

C REACTIVE PROTEIN; CD34 ANTIGEN; UREMIC TOXIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CELL COUNT; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENDOTHELIUM CELL; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEM CELL; THERAPY EFFECT; TREATMENT OUTCOME;

AGED; C-REACTIVE PROTEIN; CELL COUNT; CROSS-OVER STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; STEM CELLS; TREATMENT OUTCOME;

EID: 78649506623     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq552     Document Type: Article

References (33)

1. Hill JM, Zalos G, Halcox JPJ et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003; 348: 593-600
2. Werner N, Kosiol S, Schiegl Tet al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007 (Pubitemid 41262334)
3. De Groot K, Bahlmann FH, Sowa J et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66: 641-646
4. + cell count is associated with poor prognosis in chronic hemodialysis patients. Kidney Int 2008; 74: 1603-1609
5. Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252
6. Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 2005; 289: F679-F684
7. Krenning G, Dankers PY, Drouven JW et al. Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Am J Physiol Renal Physiol 2009; 296: F1314-F1322
8. Jourde-Chiche N, Dou L, Sabatier F et al. Levels of circulating endo-thelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients. J Thromb Haemost 2009; 7: 1576-1584
9. Ramirez R, Carracedo J, Merino A et al. Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int 2007; 72: 1008-1013
10. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1584-1595
11. Daugirdas JT. Physiologic principles and urea kinetic modeling. In: JT Daugirdas, PG Blake, TS Ing (eds). Part II. Blood-Based Therapies. Handbook of Dialysis IV edn. Wolters Kluwer/Lippincott Williams & Wilkins; pp. 25-58
12. Krieter DH, Morgenroth A, Barasinski A et al. Effects of a polyelec-trolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins. Nephrol Dial Transplant 2007; 22: 491-499
13. Ingram DA, Mead LE, Tanaka H et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-2760
14. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9: S16-S23
15. De Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789
16. Eknoyan G, Beck GJ, Cheung AK et al. Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019
17. Krane V, Krieter DH, Olschewski M et al. Dialyzer membrane characteristics and outcomeofpatients with type2 diabetesonmaintenance hemodialysis. Am J Kidney Dis 2007; 49: 267-275
18. Yoder MC. Defining human endothelial progenitor cells. J Thromb Haemost 2009; 7: 49-52
19. Ueno H, Koyama H, Fukumoto S et al. Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients. Nephrol Dial Transplant 2010; 25: 581-586
20. Hristov M, Fach C, Becker C et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007; 192: 413-420
21. Cheung AK, Rocco MV, Yan G et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006; 17: 546-555
22. Sturiale A, Coppolino G, Loddo S et al. Effects of haemodialysis on circulating endothelial progenitor cell count. Blood Purif 2007; 25: 242-251
23. Schlieper G, Hristov M, Brandenburg Vet al. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 2611-2618
24. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97
25. Xu Q. Progenitor cells in vascular repair. Curr Opin Lipidol 2007; 18: 534-539
26. George J, Goldstein E, Abashidze S et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 2004; 25: 1003-1008
27. Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
28. Wanner C, Drechsler C, Krane V. C-reactive protein and uremia. Semin Dial 2009; 22: 438-441
29. Tousoulis D, Andreou I, Antoniades C et al. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 2008; 201: 236-247
30. Fan Y, Ye J, Shen F et al. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab 2008; 28: 90-98
31. Verma S, Kuliszewski MA, Li SH et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109: 2058-2067
32. Suh W, Kim KL, Choi JH et al. C-reactive protein impairs angio-genic functions and decreases the secretion of arteriogenic chemo- cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun 2004; 321: 65-71 33. (Pubitemid 39055606)
33. Fujii H, Li SH, Szmitko PE et al. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2006; 26: 2476-2482